| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | XMD14-99 | GDSC1000 | pan-cancer | AAC | 0.0017 | 1 |
| mRNA | ML210 | CTRPv2 | pan-cancer | AAC | -0.0015 | 1 |
| mRNA | Imatinib | FIMM | pan-cancer | AAC | -0.0081 | 1 |
| mRNA | Ko-143 | CTRPv2 | pan-cancer | AAC | 0.0016 | 1 |
| mRNA | CGP-082996 | GDSC1000 | pan-cancer | AAC | -0.0024 | 1 |
| mRNA | momelotinib | CTRPv2 | pan-cancer | AAC | 0.0015 | 1 |
| mRNA | N9-isopropylolomoucine | CTRPv2 | pan-cancer | AAC | 0.0015 | 1 |
| mRNA | WZ3105 | GDSC1000 | pan-cancer | AAC | -0.0013 | 1 |
| mRNA | neopeltolide | CTRPv2 | pan-cancer | AAC | -0.0028 | 1 |
| mRNA | triazolothiadiazine | CTRPv2 | pan-cancer | AAC | -0.0011 | 1 |